In The Name of Allah Nucleic Acids DHPLC Applications in Biomedicine Pooria Gill PhD of Nanobiotechnology pooriagill@yahoo.com Nucleic Acids DNA • Man-made – Vectors – Linear • Nature-made – Genomic – Cytoplasmic • Man-made – Oligo-primer – Oligo-probe – Q-DNA – Circular • Nature-made – Mitochondric – Organoplasmic RNA • Nature-made – rRNA – mRNA – tRNA – ncRNA – tmRNA • Man-made – siRNA Applications DHPLC Systems (e.g. WAVE Systems) can be used for a wide range of applications including: – – – – – – – – Mutation Detection Sizing Oligonucleotide Purification and Analysis Forensics Microbial Analysis RNA Isolation and Purification Single Base Extension Methylation With the WAVE System you can: Scan fragments for both known and novel mutations/SNPs without extensive resequencing Detect low-abundance mutations in heterogeneous samples Enrich for low-abundance alleles Fractionate complex mixtures of related fragments based on differences in sequence content Perform targeted mutation/SNP scoring via primer extension assays Analyze end-point products from allele-specific Probe/Primerbased Amplification Technologies Probe/Primer-based Amplification Technologies • Primer-based Amplifications: – Non-Isothermal Amplifications e.g. PCR-based Methods – Isothermal Amplifications/Non-PCR-based Amplifications: – NASBA – HDA – SDA – , and more than 45 N.A.I.A. Technologies • Probe-based Amplifications: – For example: Ligase Chain Reactions CARTRIDGE dependent Applications e.g. via WAVE Systems DNA-99-3510 DNASep Cartridge 4.6 mm x 50 mm, for variety of DNA applications including Sizing and Mutation Detection, load capacity of 2µg DNA-99-3710 DNASep HT Cartridge 6.5 mm x 37 mm, for variety of DNA application but especially for Rapid Mutation Detection, load capacity of 4µg NUC-99-3550 OligoSep® Cartridge 4.6 mm x 50 mm; for Oligo Purification work only NUC-99-3860 OligoSep Prep HC Cartridge 7.8 mm x 50 mm, for Oligo Purification, load capacity of 5000µg RNA-99-3810 RNASep® Prep Cartridge 7.8 mm x 50 mm, for variety of RNA applications, load capacity of 50µg total RNA -OR- 1000ng of specific RNA Chromatograms and pedigree of patients 3 and 16. A. DHPLC analysis in normal control, patients 3 and 16. Both patients show abnormal DHPLC peak patterns with two peaks in comparison to normal control. B. Sequencing data in patient 3 and his family members. C. Sequencing data in patient 16 and his family members. Example of Oligo Analysis by DHPLC Thanks for Your Attentions Reference: